Schiller JH - Search Results

1

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer.

Sandler A, Gray R, Perry MC, Brahmer J, Schiller JH, Dowlati A, Lilenbaum R, Johnson DH. Sandler A, et al. Among authors: schiller jh. N Engl J Med. 2006 Dec 14;355(24):2542-50. doi: 10.1056/NEJMoa061884. N Engl J Med. 2006. PMID: 17167137 Free article. Clinical Trial.

2

Phase II trial of oral etoposide plus cisplatin in extensive stage small cell carcinoma of the lung: an Eastern Cooperative Oncology Group study.

Schiller JH, Ettinger DS, Larson MM, Gradishar W, Merkel D, Johnson DH. Schiller JH, et al. Eur J Cancer. 1994;30A(2):158-61. doi: 10.1016/0959-8049(94)90078-7. Eur J Cancer. 1994. PMID: 8155389 Clinical Trial.

3

Phase II study of topotecan in patients with extensive-stage small-cell carcinoma of the lung: an Eastern Cooperative Oncology Group Trial.

Schiller JH, Kim K, Hutson P, DeVore R, Glick J, Stewart J, Johnson D. Schiller JH, et al. J Clin Oncol. 1996 Aug;14(8):2345-52. doi: 10.1200/JCO.1996.14.8.2345. J Clin Oncol. 1996. PMID: 8708727 Clinical Trial.

4

Lung cancer: review of the ECOG experience. Eastern Cooperative Oncology Group.

Schiller JH, Cleary J, Johnson D. Schiller JH, et al. Oncology. 1997 Sep-Oct;54(5):353-62. doi: 10.1159/000227718. Oncology. 1997. PMID: 9260595 Review.

5

Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small-cell lung cancer on E4592: a Laboratory Ancillary Study on an Eastern Cooperative Oncology Group Prospective Randomized Trial of Postoperative Adjuvant Therapy.

Schiller JH, Adak S, Feins RH, Keller SM, Fry WA, Livingston RB, Hammond ME, Wolf B, Sabatini L, Jett J, Kohman L, Johnson DH. Schiller JH, et al. J Clin Oncol. 2001 Jan 15;19(2):448-57. doi: 10.1200/JCO.2001.19.2.448. J Clin Oncol. 2001. PMID: 11208838 Clinical Trial.

6

Topotecan versus observation after cisplatin plus etoposide in extensive-stage small-cell lung cancer: E7593--a phase III trial of the Eastern Cooperative Oncology Group.

Schiller JH, Adak S, Cella D, DeVore RF 3rd, Johnson DH. Schiller JH, et al. J Clin Oncol. 2001 Apr 15;19(8):2114-22. doi: 10.1200/JCO.2001.19.8.2114. J Clin Oncol. 2001. PMID: 11304763 Clinical Trial.

7

Current standards of care in small-cell and non-small-cell lung cancer.

Schiller JH. Schiller JH. Oncology. 2001;61 Suppl 1:3-13. doi: 10.1159/000055386. Oncology. 2001. PMID: 11598409 Review.

8

Outcome of patients with a performance status of 2 in Eastern Cooperative Oncology Group Study E1594: a Phase II trial in patients with metastatic nonsmall cell lung carcinoma.

Sweeney CJ, Zhu J, Sandler AB, Schiller J, Belani CP, Langer C, Krook J, Harrington D, Johnson DH. Sweeney CJ, et al. Cancer. 2001 Nov 15;92(10):2639-47. doi: 10.1002/1097-0142(20011115)92:10<2639::aid-cncr1617>3.0.co;2-8. Cancer. 2001. PMID: 11745199 Clinical Trial.

9

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer.

Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, Krook J, Zhu J, Johnson DH; Eastern Cooperative Oncology Group. Schiller JH, et al. N Engl J Med. 2002 Jan 10;346(2):92-8. doi: 10.1056/NEJMoa011954. N Engl J Med. 2002. PMID: 11784875 Free article. Clinical Trial.

10

The influence of gender on survival and tumor recurrence following adjuvant therapy of completely resected stages II and IIIa non-small cell lung cancer.

Keller SM, Vangel MG, Adak S, Wagner H, Schiller JH, Herskovic A, Komaki R, Perry MC, Marks RS, Livingston RB, Johnson DH. Keller SM, et al. Among authors: schiller jh. Lung Cancer. 2002 Sep;37(3):303-9. doi: 10.1016/s0169-5002(02)00103-4. Lung Cancer. 2002. PMID: 12234700 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

243 results

Search Page